Work

MDV3100-08: A phase I open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of MDV3100 in women with incurable breast cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.tps668

Authors: Anthony D. Elias, Jennifer K. Richer, Patricia LoRusso, Amy C. Peterson, Joyce Leta Steinberg, Joyce Mordenti, Christian Lopez, Clifford Hudis, Tiffany A. Traina

Institutions: University of Colorado Anschutz, The Barbara Ann Karmanos Cancer Institute, Medivation, Inc. (United States), Astellas Pharma (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2728762065

Cites:

Cited by: 2

Related to: 10